Document is current
Any future updates will be listed below
-
Authors
Griffiths, Cara A.
Xue, Xiaochao
Miret, Javier A. https://orcid.org/0000-0001-8897-1212
Salvagiotti, Fernando
Acevedo-Siaca, Liana G.
Gimeno, Jacinta
Reynolds, Matthew P. https://orcid.org/0000-0002-4291-4316
Hassall, Kirsty L.
Halsey, Kirstie
Puranik, Swati
Oszvald, Maria
Kurup, Smita https://orcid.org/0000-0003-1035-7065
Davis, Benjamin G. https://orcid.org/0000-0002-5056-407X
Paul, Matthew J. https://orcid.org/0000-0002-2001-961X
-
Funding
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/D006112/1, BB/R019606/1, BB/S01280X/1, BB/P016855/1, BB/X011003/1)
RCUK | Engineering and Physical Sciences Research Council (EP/V011359/1)
- License Information
-
More Information
Article History
Received: 4 June 2024
Accepted: 21 February 2025
First Online: 29 April 2025
Competing interests
: C.A.G., B.G.D. and M.J.P. are founders and shareholders of SugaROx, which holds rights to the commercial exploitation of DMNB-T6P. C.A.G. is a part-time employee of SugaROx. M.O. is a full-time employee of SugaROx. Patents have been filed on the use of DMNB-T6P, on which C.A.G., B.G.D. and/or M.J.P. are named as inventors. No part of this study involved SugaROx. The remaining authors declare no competing interests.
